Using LC-MS Approaches to Improve on Traditional Bioanalysis Methods
Learn how the Bioanalysis Department at LGC is implementing LC-MS to improve services
31 Jan 2017
The Bioanalysis Department of LGC is utilizing LC-MS technology
The main focus of my work is ensuring scientific quality throughout everything we do, from method development through to analysis
Dr Catarina Horro Pita,
Drug Development Services, LGC
SelectScience® interviewed two scientists working within the Bioanalysis Department at LGC to find out how they were implementing LC-MS/MS to improve the analysis of both small and large molecules.
Dr Catarina Horro Pita, a Principal Scientist who is specialized in small molecule analysis, described how she is currently working on the way biomarkers are validated at LGC. She explained that rather than using a pharmacokinetic approach, they are working on more suitable strategies to measure endogenous analytes using LC-MS/MS. Watch the full interview to find out more.
Kjetil Hansen, another scientist in the department, explained how LC-MS has increased selectivity in comparison to the traditional immunoassay analysis. He went onto describe the process of protein digestion, initial peptide screening using Q-TOF and finally analysis of the chosen peptide on a triple quadruple mass spectrometry. To learn more, watch the full interview.
Watch the interview on biomarker analysis or large molecule analysis and visit LGC’s company profile to find out more about its services.
Leave a product review today to be entered into a prize draw for the chance to win an iPad or $400 Amazon voucher (or equivalent currency).
Related Products
Request Quote for All Products
Bioanalysis of peptides service
ResolianOur industry leading bioanalytical solutions have helped our clients develop new peptide therapeutics to improve the quality of life. Combining our experience and cutting-edge technology, we have has developed and validated methods using LC-MS/MS to quantify levels of peptides in plasma at levels as low as 10 pg/mL.
Biomarker testing service
ResolianBiomarker strategy is critical to success. Our personalized biomarker solutions help drive your development to market. The expert biomarker teams support non-clinical and clinical biomarker method development, validation, and sample analysis.
Small Molecule Bioanalysis Service
ResolianFocused strategic science team, and one of the largest purpose-built bioanalytical facilities in Europe.